Entry |
|
Name |
Farber lipogranulomatosis; Farber disease |
Supergrp |
Defects in the degradation of sphingomyelin [DS: H00424] Sphingolipidosis [DS: H00423] Lysosomal storage disease [DS: H01425] |
Description |
Farber lipogranulomatosis is an autosomal recessive disorder caused by acid ceramidase deficiency.
|
Category |
Inherited metabolic disorder, Lysosomal disease
|
Brite |
Human diseases in ICD-11 classification [BR:br08403]
05 Endocrine, nutritional or metabolic diseases
Metabolic disorders
Inborn errors of metabolism
5C56 Lysosomal diseases
H00138 Farber lipogranulomatosis
Pathway-based classification of diseases [BR:br08402]
Lipid/glycolipid metabolism
nt06014 Sphingolipid degradation
H00138 Farber lipogranulomatosis
|
Pathway |
|
Network |
|
Gene |
|
Other DBs |
|
Reference |
|
Authors |
Heese BA |
Title |
Current strategies in the management of lysosomal storage diseases. |
Journal |
|
Reference |
|
Authors |
Park JH, Schuchman EH |
Title |
Acid ceramidase and human disease. |
Journal |
|
Reference |
|
Authors |
Wenger DA, Coppola S, Liu SL |
Title |
Insights into the diagnosis and treatment of lysosomal storage diseases. |
Journal |
|
Reference |
|
Authors |
Bar J, Linke T, Ferlinz K, Neumann U, Schuchman EH, Sandhoff K |
Title |
Molecular analysis of acid ceramidase deficiency in patients with Farber disease. |
Journal |
|
LinkDB |
|